Independent import-duty reference  /  US customs dataRates as of 11/22/2026 17:06 EST

HTS 3003 · India · duty record

Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale

Goods in HTS heading 3003 from India pay the general duty in the tariff schedule, and the rules in our table add nothing on top. Across the 15 lines below the percentage total runs from 0% to 0%. Section 232 is added to the totals only where a plain percentage applies to the line and the country (conditional and country-deal rates are listed, not added), we found no IEEPA duty in force, and antidumping duties are not checked here.

15 ten-digit lines0% to 0% percentage rangeRates as of 11/22/2026 17:06 EST2026HTSRev23
Landed-cost calculator

Selected line / duty components

3003.10.00.00
0%Total percentage

General schedule rate: Free

Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale › Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives

On $10,000 customs value (percentage part): $0.00
Section 232 · conditional and country-deal rates not addedAD/CVD · none found in our listIEEPA · none found in force

Click any code in the table below to show that line here.

Duty by line

15 tariff lines · India

Pick your own 10-digit code from your classification or broker: the rate that applies to you is the one on your line. The last column is the percentage part only, on $10,000 of customs value.

15 lines shown

CodeProductGeneral rateAdded dutiesTotal percentageOn $10,000
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale › Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivativesFreenone in our table0%$0.00
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale › Other, containing antibioticsFreenone in our table0%$0.00
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale › Containing insulinFreenone in our table0%$0.00
Other › Artificial mixtures of natural hormonesFreenone in our table0%$0.00
Other › OtherFreenone in our table0%$0.00
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale › Containing ephedrine or its saltsFreenone in our table0%$0.00
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale › Containing pseudoephedrine (INN) or its saltsFreenone in our table0%$0.00
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale › Containing norephedrine or its saltsFreenone in our table0%$0.00
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale › OtherFreenone in our table0%$0.00
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale › Other, containing antimalarial active principles described in subheading note 2 to this chapterFreenone in our table0%$0.00
Anti-infective medicaments › AntiviralsFreenone in our table0%$0.00
Anti-infective medicaments › AntifungalsFreenone in our table0%$0.00
Anti-infective medicaments › Antiprotozoals (excluding goods described in subheading note 2 to this chapter)Freenone in our table0%$0.00
Anti-infective medicaments › OtherFreenone in our table0%$0.00
Other › OtherFreenone in our table0%$0.00

What is and is not counted

LayerStatusNote
General (column 1) duty
Included
USITC Harmonized Tariff Schedule 2026HTSRev23
Section 301
Included where a rule in our table applies
China's older lists (Lists 1, 2, 3, 4A and the 2024 four-year-review increases) are loaded by product code with the exclusions now in force; the 2026 country action is loaded by country, with set totals for the EU, Japan, South Korea, Switzerland and Taiwan. Country-specific exemption lists (USMCA goods, CAFTA-DR textiles, UK and EU lists) are not modelled. Confirm each line with a broker. USTR: Section 301 investigations · USITC Harmonized Tariff Schedule, chapter 99
Section 232
Partly included: plain-percentage rows are added, conditional and country-deal rates are shown but not added
Plain-percentage rows from the USITC chapter 99 notes are added, one row per line (vehicles and parts ahead of metals ahead of wood); conditional and country-deal rates are listed, not added. Light-vehicle parts and truck parts are both 25% and the schedule does not say whether a part on both lists pays once or twice: the site shows one. Official source: CBP: Section 232 steel and aluminum FAQs · Commerce (BIS): Section 232 investigations
IEEPA / reciprocal
Checked: none in force found
We found no IEEPA or reciprocal duty in force. The nine IEEPA tariff actions named in Executive Order 14389 were ended by it (signed 2026-02-20), and the temporary 10% Section 122 surcharge that followed was set to expire on 2026-07-24 with no extension found in the Federal Register. A Section 301 action that began on 2026-07-24 is counted in the Section 301 layer above. Canada has a separate Section 338 duty on some products; we cannot say which lines. Official source: Federal Register: Executive Order 14389, Ending Certain Tariff Actions · Federal Register: Proclamation 11012, temporary import surcharge · CBP: IEEPA tariff FAQs
Antidumping / countervailing (AD/CVD)
None found in our list
None found in our list of 757 orders; the list can miss orders newer than their first review notice. Official source: CBP: antidumping and countervailing duty · Commerce (ITA): ACCESS case search · CBP: AD/CVD case data and search · Commerce: ADCVD proceedings

Section 232: what the proclamations say about chapter 30

These are summaries of the official proclamations. Where the tariff schedule notes give a plain percentage for your line and country, it is already in the duty above (see the layer list). Rates that depend on a fact only you know (the share of metal by weight, U.S.-made metal, a country deal, a USMCA claim) are listed but not added. Check your own line against the official list or ask your broker.

Pharmaceuticals and pharmaceutical ingredients in force

  • Proclamation 11020 (2026-04-09). USITC HTS 2026HTSRev23, U.S. note 40 and headings 9903.04.60 to 9903.04.70. Patented pharmaceutical articles: total rate 100% (heading 9903.04.60); 15% total for products of Japan, the EU, South Korea, Switzerland and Liechtenstein (9903.04.62); the United Kingdom +0% (9903.04.63); +20% for companies with an approved onshoring plan (9903.04.64). Generic products, orphan drugs, nuclear medicines, plasma therapies, fertility treatments, cell and gene therapies, clinical-trial products and several other groups pay nothing extra (9903.04.61, .65 to .70).
  • Product list (added 2026-11-21): 149 code prefixes parsed from note 40(c) (chapters 29 and 30). Whether the duty applies depends on patent status and the importer, which the product code cannot show, so every row is listed and none is added to totals. The pack holds neither chapter 29 nor chapter 30, so no tariff line of the site resolves to these rows yet.

Read from the proclamation on 2026-11-21. Sources: Proclamation 11020 (Federal Register document 2026-06956)

Pending and recent notices for this heading